Brain scans reveal sex differences in Smokers' glutamate levels
NCT ID NCT05279053
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how smoking affects a brain chemical called glutamate in men versus women. Researchers scanned the brains of 58 smokers after not smoking overnight and after their first cigarette of the day. They also measured hormone levels in women to see if hormones influence brain chemistry. The goal was to better understand sex differences in smoking addiction, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
58 people
The number who actually took part.
- Started
-
Apr 2021
- Finished
-
Mar 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Target recruitment: 60 adult daily smokers (30 men and 30 women; 18-45 years old), who are otherwise in good health. Interested individuals will be invited to participate in the research project regardless of sex, race or ethnicity, although strong efforts will be made to recruit equal numbers of male and female participants. Individuals will not be excluded from study participation based on race/ethnicity.
- Ages
-
18 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Self-identified as only male or female 2. Age 18-45 years (children \<18 years will be excluded due to low prevalence of conventional cigarette smoking; female participants \>45 years of age will be excluded to avoid effects of perimenopause and menopause in women; male participants \>45 years of age will be excluded as well to ensure that male and female groups are matched on age 3. English fluency demonstrated by verbal skills sufficient to participate in a conversation, including the ability to ask and answer questions at a level that assures adequate understanding of the study (a comprehension quiz will be given) 4. Right handedness (evaluated using the Edinburgh Inventory) 5. Generally in good health without cardiovascular, hepatic, renal, or autoimmune diseases, diabetes, or cancer 6. Must have smoked for ≥1 year 7. Must endorse inhaling while smoking 8. Must smoke ≥10 cigarettes per day 9. Must have expired CO \>10 ppm and urinary cotinine ≥100 ng/ml at screening/intake 10. Fulfillment of DSM-5 criteria for Tobacco Use Disorder Exclusion Criteria: 1. Seeking treatment for nicotine dependence within 3 months of screening 2. Medical condition that may compromise safety (based on history, physical exam) 3. Neurological disorder that would compromise compliance and/or informed consent 4. Major psychiatric disorder (e.g., Major Depression, Schizophrenia, Bipolar Disorder) per DSM-5 MINI 5. Current drug use disorders other than Tobacco Use Disorder (as defined in DSM-5) 6. Recent use of cocaine, opiates, benzodiazepines, or amphetamines as shown by urine test at the screening or testing sessions 7. Smoke marijuana \>3X/week (self-report) or positive marijuana urine test on a scan day (positive at screening allowed) 8. Use of tobacco in forms other than cigarettes (e.g., snuff, chewing tobacco, e-cigarettes) \>10 days in the month before screening 9. Preference for menthol cigarettes, given sex differences in the effect of menthol on the rate of nicotine entry into the brain 10. Pregnancy or nursing 11. Presence in the body of metal that would compromise safety during MRI 12. Claustrophobia 13. Any other condition that would compromise safety
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cigarette smoking are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA Semel Institute
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texts and wearables team up to help latinos quit smoking and get moving
- Can a WhatsApp message help smokers quit?
- Can a brain scan tailor TMS to quiet cigarette cravings?
- Can a combined program help veterans in substance use care quit smoking?
- Could a health Worker's support break the smoking habit in mental illness?
- Mindfulness meets wearable tech in a new bid to break the smoking habit